Research Highlights

Artificial intelligence reveals COVID-19 lung damage

Published online 1 June 2022

Scientists use AI to enhance the resolution of lung abnormalities in CT scans.

Biplab Das

These images are from a COVID-19 survivor with severe post-COVID complications. The upper parts are visualizations by traditional methods: everything looks normal. The lower parts are DLPE enhanced, where healthy parts are black and lesions are white: many subvisual lesions are unveiled.
These images are from a COVID-19 survivor with severe post-COVID complications. The upper parts are visualizations by traditional methods: everything looks normal. The lower parts are DLPE enhanced, where healthy parts are black and lesions are white: many subvisual lesions are unveiled.
Longxi Zhou Enlarge image
Scientists have developed a computer-aided detection method to reveal hidden signs of lung damage in CT scans of people who were admitted to hospital following COVID-19 infection and went on to suffer long-term respiratory complications. 

The Deep-Lung Parenchyma-Enhancing (DLPE) approach calculates the optimal signal window for observing normally invisible lung lesions in CT scans. Existing methods, including computer-based ones, fail to detect this damage, which appears in CT scans as ground-glass opacities, which describes a scratched-looking surface, and lung scars.

Normally, to view lung lesions, radiologists need to reduce the CT signal range to what is called the lung window. But the signals coming from sub-visual lesions and healthy background tissue when viewed within this window are not very distinct from each other. Also, blood vessels and airways have strong CT signals, further hampering the ability to see the lung lesions. “DLPE calculates the scan-optimal window for observing the lesions in individual patients, enhancing them dozens of times and making them visible,” explains PhD computer science student, Longxi Zhou from King Abdullah University of Science and Technology (KAUST) in Saudi Arabia. 

The research team, from Saudi Arabia and China, trained their model using thousands of CT scans from healthy people and people who were hospitalized with COVID-19, who remain ill. Without DLPE, they were only able to detect a small volume of lesions, whereas DLPE allowed them to find a much larger volume. 

“We also found that the method dramatically improved the prediction of key clinical metrics, like the gas exchange ratio in the lungs, by assessing the volume of the lesions,” says KAUST computer scientist, and computational biologist, Xin Gao. 

The researchers say that such knowledge will help clinicians assess the extent of lung damage, and determine the desired therapy. 

The method could also be used to detect mild lung tissue scarring and decipher minute features of various lung diseases like pneumonia, tuberculosis and lung cancers. 

doi:10.1038/nmiddleeast.2022.29


Zhou, L. et al. An interpretable deep learning workflow for discovering subvisual abnormalities in CT scans of COVID-19 inpatients and survivors. Nat. Mach. Intell. https://doi.org/10.1038/s42256-022-00483-7 (2022).